Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Demographic and clinical characteristics of IMD patients between 2009 and 2015 in Germany.

More »

Table 1 Expand

Fig 1.

Mean overall costs in Euro (€) of IMD cases within pre-defined follow-up periods after diagnosis and stratified by clinical presentation of IMD.

IMD = Invasive meningococcal disease; Data for other IMD in the time period 5 to 7 years could not be displayed due to data protection reasons (n<5); further information on SD and costs by clinical presentation of IMD in each healthcare sector is available in S2 Appendix.

More »

Fig 1 Expand

Table 2.

Adjusted ratio of length of stay of IMD-related index hospitalization (2009–2015).

More »

Table 2 Expand

Table 3.

Adjusted cost ratios of total costs per day during IMD-related index hospitalization (2009–2015).

More »

Table 3 Expand

Table 4.

Adjusted cost ratios of total cost per day during the overall follow up period after discharge from IMD-related index hospitalization for all IMD patients.

More »

Table 4 Expand

Table 5.

Rate ratios of healthcare resource utilization during the study follow-up period (IMD cases vs. matched controls, 2009–2015).

More »

Table 5 Expand

Fig 2.

Mean costs (in Euro = €) of IMD cases and matched controls without IMD within pre-defined follow-up periods after IMD diagnosis, overall and stratified by healthcare sector.

* statistically significant at bootstrap p-value <0.05 obtained from two-part regression model composed of a logistic regression model in all patients with an indicator of non-zero costs as dependent variable, and a gamma regression model in patients with costs greater zero with costs as dependent variable; IMD = Invasive meningococcal disease; based on data from n = 147 IMD cases and n = 567 matched controls without IMD.

More »

Fig 2 Expand

Table 6.

Adjusted cost ratios of healthcare resource utilization during the study follow-up period (IMD cases vs. matched controls, 2009–2015).

More »

Table 6 Expand